These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 32838355)

  • 1. Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.
    Magagnoli J; Narendran S; Pereira F; Cummings TH; Hardin JW; Sutton SS; Ambati J
    Med; 2020 Dec; 1(1):114-127.e3. PubMed ID: 32838355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19.
    Magagnoli J; Narendran S; Pereira F; Cummings T; Hardin JW; Sutton SS; Ambati J
    medRxiv; 2020 Apr; ():. PubMed ID: 32511622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.
    Gerlovin H; Posner DC; Ho YL; Rentsch CT; Tate JP; King JT; Kurgansky KE; Danciu I; Costa L; Linares FA; Goethert ID; Jacobson DA; Freiberg MS; Begoli E; Muralidhar S; Ramoni RB; Tourassi G; Gaziano JM; Justice AC; Gagnon DR; Cho K
    Am J Epidemiol; 2021 Nov; 190(11):2405-2419. PubMed ID: 34165150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of azithromycin and hydroxychloroquine in patients hospitalized with COVID-19: Network meta-analysis of randomized controlled trials.
    Chi G; Memar Montazerin S; Lee JJ; Kazmi SHA; Shojaei F; Fitzgerald C; Gibson CM
    J Med Virol; 2021 Dec; 93(12):6737-6749. PubMed ID: 34370328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
    Stewart M; Rodriguez-Watson C; Albayrak A; Asubonteng J; Belli A; Brown T; Cho K; Das R; Eldridge E; Gatto N; Gelman A; Gerlovin H; Goldberg SL; Hansen E; Hirsch J; Ho YL; Ip A; Izano M; Jones J; Justice AC; Klesh R; Kuranz S; Lam C; Mao Q; Mataraso S; Mera R; Posner DC; Rassen JA; Siefkas A; Schrag A; Tourassi G; Weckstein A; Wolf F; Bhat A; Winckler S; Sigal EV; Allen J
    PLoS One; 2021; 16(3):e0248128. PubMed ID: 33730088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study.
    Saib A; Amara W; Wang P; Cattan S; Dellal A; Regaieg K; Nahon S; Nallet O; Nguyen LS
    PLoS One; 2021; 16(6):e0252388. PubMed ID: 34106964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-Life Data on Hydroxychloroquine or Chloroquine with or Without Azithromycin in COVID-19 Patients: A Retrospective Analysis in Brazil.
    Souza-Silva MVR; Pereira DN; Pires MC; Vasconcelos IM; Schwarzbold AV; Vasconcelos DH; Pereira EC; Manenti ERF; Costa FR; Aguiar FC; Anschau F; Bartolazzi F; Nascimento GF; Vianna HR; Batista JDL; Machado-Rugolo J; Ruschel KB; Ferreira MAP; Oliveira LS; Menezes LSM; Ziegelmann PK; Tofani MGT; Bicalho MAC; Nogueira MCA; Guimarães-Júnior MH; Aguiar RLO; Rios DRA; Polanczyk CA; Marcolino MS
    Arq Bras Cardiol; 2023 Sep; 120(9):e20220935. PubMed ID: 37878893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin.
    Kelly M; O'Connor R; Townsend L; Coghlan M; Relihan E; Moriarty M; Carr B; Melanophy G; Doyle C; Bannan C; O'Riordan R; Merry C; Clarke S; Bergin C
    Br J Clin Pharmacol; 2021 Mar; 87(3):1150-1154. PubMed ID: 32687645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.
    Duška F; Waldauf P; Halačová M; Zvoníček V; Bala J; Balík M; Beneš J; Klementová O; Kozáková I; Kubricht V; Le Roy A; Vymazal T; Řehořová V; Černý V;
    Trials; 2020 Jul; 21(1):631. PubMed ID: 32641163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID-19.
    Lauriola M; Pani A; Ippoliti G; Mortara A; Milighetti S; Mazen M; Perseghin G; Pastori D; Grosso P; Scaglione F
    Clin Transl Sci; 2020 Nov; 13(6):1071-1076. PubMed ID: 32926573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
    Million M; Lagier JC; Tissot-Dupont H; Ravaux I; Dhiver C; Tomei C; Cassir N; Delorme L; Cortaredona S; Amrane S; Aubry C; Bendamardji K; Berenger C; Doudier B; Edouard S; Hocquart M; Mailhe M; Porcheto C; Seng P; Triquet C; Gentile S; Jouve E; Giraud-Gatineau A; Chaudet H; Camoin-Jau L; Colson P; Gautret P; Fournier PE; Maille B; Deharo JC; Habert P; Gaubert JY; Jacquier A; Honore S; Guillon-Lorvellec K; Obadia Y; Parola P; Brouqui P; Raoult D
    Rev Cardiovasc Med; 2021 Sep; 22(3):1063-1072. PubMed ID: 34565108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis.
    Budhathoki P; Shrestha DB; Khadka S; Rawal E
    J Nepal Health Res Counc; 2021 Apr; 19(1):1-9. PubMed ID: 33934125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
    Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of QT Prolongation with Hydroxychloroquine and Azithromycin for the Treatment of COVID-19.
    Seyhan AU; Doganay F; Yilmaz E; Topal NP; Ak R
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):153-157. PubMed ID: 33291194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
    Özdemir İH; Özlek B; Özen MB; Gündüz R; Çetin N; Bilge AR
    Int J Clin Pract; 2021 Feb; 75(2):e13896. PubMed ID: 33280207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
    O'Connell TF; Bradley CJ; Abbas AE; Williamson BD; Rusia A; Tawney AM; Gaines R; Schott J; Dmitrienko A; Haines DE
    JACC Clin Electrophysiol; 2021 Jan; 7(1):16-25. PubMed ID: 33478708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine / azithromycin in COVID-19: The association between time to treatment and case fatality rate.
    Accinelli RA; Ynga-Meléndez GJ; León-Abarca JA; López LM; Madrid-Cisneros JC; Mendoza-Saldaña JD
    Travel Med Infect Dis; 2021; 44():102163. PubMed ID: 34534686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital.
    Paccoud O; Tubach F; Baptiste A; Bleibtreu A; Hajage D; Monsel G; Tebano G; Boutolleau D; Klement E; Godefroy N; Palich R; Itani O; Faiçal A; Valantin MA; Tubiana R; Burrel S; Calvez V; Caumes E; Marcelin AG; Pourcher V
    Clin Infect Dis; 2021 Dec; 73(11):e4064-e4072. PubMed ID: 32556143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.